Not only in medicine, but also in agriculture there is a lack of active compounds: infectious diseases can no longer be treated efficiently, pests of globally important crops can no longer be adequately fought. However, the development of new, safer drugs for medicine and for food and agriculture poses an enormous challenge for applied research. To identify such compounds, research on new substances and the development of innovative production technologies must be enhanced and include novel methods.
Bundling of competences
The Leibniz Research Cluster Bio/Synthetic Micro-Productions Units – New Ways in Drug Development therefore puts a pioneering idea into practice: Expertise in biotechnology is combined with engineering science to improve the methods used to search for new drugs. Moreover, new technologies, for example taken up from materials research and microfluidics, are being integrated into existing production processes, creating urgently needed building blocks for the synthesis of active compounds.
Partner of the Leibniz Research Cluster receives seal of excellence // 27.09.2018 The Leibniz Institute for Natural Product Research and Infection Biology in Jena is part of the cluster of excellence Balance of the Microverse.